6 results
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
. Genmab has conducted scenario analysis on the potential transition and physical risks and opportunities related to climate change, at 1.5—2°C and 4°C … of potential risks identified 4°C, medium/long term: ― Transition risk resulting from fragmented regulatory efforts to curb runaway climate change through
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
transition and physical risks and opportunities related to climate change, at 1.5 – 2°C and 4°C of warming, across our value chain, in the short term … climate change through cost of compliance with carbon taxation, pricing, etc.
Physical risk resulting from acute, severe and frequent extreme weather
6-K
EX-99.1
GMAB
Genmab
16 Feb 22
Genmab 2021 Annual Report
11:29am
a scenario analysis to evaluate our risks and opportunities due to the rapid pace of world climate change. Genmab’s climate strategy, progress toward … has conducted scenario analysis on the potential transition and physical risks and opportunities related to climate change, at 1.5 - 2°C and 4°C
6-K
EX-99.1
xrhx0nrx6jy
16 Feb 22
Genmab 2021 Annual Report
11:29am
- Prev
- 1
- Next